SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders
I'm PortAI, I can summarize articles.
Halper Sadeh LLC is investigating the fairness of the proposed sale of scPharmaceuticals Inc. (NASDAQ: SCPH) to MannKind Corporation for $5.35 per share plus contingent value rights. The firm questions whether the scPharmaceuticals board acted in the best interest of shareholders and whether MannKind is underpaying. They may seek increased consideration and additional disclosures for shareholders. Halper Sadeh LLC operates on a contingent fee basis, representing investors affected by corporate misconduct.
Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments